During the past decade, Henry Ford Hosp. CRS conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Hosp. CRS" #1 collaborator was "Chiron Corporation" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Hosp. CRS" are "HIV Infections" (14 trials), "Anus Neoplasms" (1 trials), "Cardiovascular Diseases" (1 trials), "HIV Infection" (1 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "Henry Ford Hosp. CRS" in a lesser frequency.

Most popular intervention types in "Henry Ford Hosp. CRS" are "Drug" (9 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darunavir" (2 trials), "Placebo" (2 trials), "Raltegravir" (2 trials), "Antiretroviral Regimens" (1 trials) and "Atazanavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Hosp. CRS" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Henry Ford Hosp. CRS". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Henry Ford Hosp. CRS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Hosp. CRS, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".